3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
16
Recruiting
9
Active not recruiting
8
Withdrawn
4
Terminated
4
Unknown
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Conditions
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
63
Cisplatin
40
Pemetrexed
38
Drug Therapy
37
osimertinib
22
anlotinib
22
Etoposide
20
tislelizumab
17
Radiotherapy
17
Paclitaxel
17
Surgical Procedures, Operative
16
pembrolizumab
15
toripalimab
14
130-nm albumin-bound paclitaxel
14
aflutinib
13
Docetaxel
13
Bevacizumab
12
sintilimab
10
Specimen Handling
10
Magnetic Resonance Spectroscopy
10
Injections
9
durvalumab
8
cemiplimab
8
Radiosurgery
8
Platinum
8
PM 01183
8
Immunotherapy
8
atezolizumab
7
Platinum Compounds
7
Blood Specimen Collection
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Ramucirumab
×
Thoracic
×
Clear all
NCT07603856
2026-05-22
REVIVE
University of Chicago
Phase 2
Not yet recruiting
39 enrolled